PR Newswire
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
📈
AI Sentiment
Highly Positive
8/10
Anixa Biosciences Inc. News
Latest updates and market news for ANIX
1 news
Feb 1 - Feb 7, 2026
Page 1
Share this news page